Connectivity map analysis indicated that salinomycin has similar effects as terfenadine, known to induce ROS, and niclosamide, an inhibitor of NF-κB. The decrease in NF-κB activity in salinomycin-exposed cells was validated in prostate cancer cells. Here, NFKB1 is linked to prostate cancer.